title: Metabolic abnormalities in lymphoma.
abstract: Metabolic abnormalities occur relatively frequently in lymphoma patients undergoing chemotherapy. These abnormalities include hyperuricemia, hypercalcemia, hyperphosphatemia, hypocalcemia, hypomagnesemia, hyponatremia, and hyperkalemia. In addition, tumor lysis syndrome can result in several metabolic abnormalities, leading to potential renal failure. If these syndromes are identified promptly, they can be corrected. Guidelines for identifying metabolic abnormalities in lymphoma patients, as well as management suggestions, are presented
authors.affiliation: Centro de Cancer Auxilio Mutuo, San Juan, Puerto Rico. cabanillas@auxilio.com
authors.forename: Fernando
authors.initials: F
authors.lastname: Cabanillas
mesh_terms: D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D018943:Anthracyclines / Q000627:therapeutic use; D002455:Cell Division; D003404:Creatinine / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006996:Hypocalcemia / Q000378:metabolism; D017674:Hypophosphatemia / Q000378:metabolism; D008223:Lymphoma / Q000378:metabolism*; D008297:Male; D051437:Renal Insufficiency / Q000378:metabolism; D013997:Time Factors; D015275:Tumor Lysis Syndrome / Q000378:metabolism; D014503:Urate Oxidase / Q000378:metabolism* / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism
chemical_list: D018943:Anthracyclines; D004791:Enzyme Inhibitors; D014527:Uric Acid; D000493:Allopurinol; D003404:Creatinine; D014503:Urate Oxidase